PPRX-1701

N/A

Report date: 2026/01/22 16:42:30

NME

Base Information

Drug NamePPRX-1701

Drug Alias Namea nanoparticle formulation of 6'-bromoindirubin acetoximea deliverable nanoparticle formulation of 6-bromo-acetoximePPRX-1701

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors

TargetsIndoleamine 2,3-dioxygenase

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States Minor Outlying Islands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPhosphorex Inc

China Registration ClassN/A

Active CompaniesPhosphorex Inc

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

ATC CodeN/A